Divi's Laboratories stock reached a new record high in July 2026. Chart patterns indicate continued upward momentum for the ...

Welcome to the Divis Labs Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...

YES Bank, a widely-track stock with 59,17,870 retail investors as of June 30, has a consensus target of Rs 20.90 against its ...

To be eligible for these payouts, investors must be mindful of the ex-dividend date, which is the day the share price adjusts ...

Macquarie's Kunal Dhamesha expects currency depreciation to offset part of the earnings drag from the absence of key generic ...

Indian stock markets on Thursday failed to hold on to their early gains and ended flat in a volatile session, weighed down by ...

The Indian Stock Markets on Thursday failed to hold on to their early gains and ended flat in a volatile session. Indices were weighed down by weak global cues and profit booking.

Astral, Divis, Eicher drove Marcellus CCP gains. Marcellus CCP shifted from large-cap consumption. New focus: healthcare, ...

Powered by a rally in the pharma stocks, Nifty pharma index hit a record high of 26,103 in the current session. The index has ...

Divis Laboratories Ltd is quoting at Rs 7296, up 1.5% on the day as on 12:44 IST on the NSE. The stock is up 6.81% in last one year as compared to a 4.17% fall in NIFTY and a 15.39% fall in the Nifty ...

The brokerage expects supplies for GLP-1 molecules to begin in FY27, while two key oral peptide opportunities, Enlicitide and ...

Axis Direct said that SBI Cards confirmed a short-term trend reversal on the daily charts by forming a double bottom ...